Tag Archives: Challenges

Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges

Sage Therapeutics has the first-ever approval for a prescription drug for postpartum depression, thanks to the FDA’s Tuesday nod for Zulresso. But it also has a number of big challenges ahead. Regulators greenlighted the product—a one-time injection—after a three-month delay, which they took to give themselves some extra time to work on a risk evaluation… Read More »

No Pain, No Gain: R&D Challenges for Success of Microneedle Systems

Perhaps because of unrealistic expectations such as completely pain-free drug injections, and also due to their R&D challenges, no microneedle products have yet reached the market. Now, with the first microneedle devices for drug delivery breaking through into the later stages of clinical trials [1] [2], companies are coming around to the real and unique… Read More »